Severe acute respiratory syndrome coronavirus 2 antibodies in pregnant women admitted to labor and delivery units. 2021

Lylach Haizler-Cohen, and Adi Davidov, and Matthew J Blitz, and Gary Fruhman
Department of Obstetrics and Gynecology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Staten Island University Hospital, Northwell Health, 475 Seaview Ave., Staten Island, NY 10305. Electronic address: lhaizlerco@northwell.edu.

UI MeSH Term Description Entries
D009518 New York State bounded on the north by Lake Ontario and Canada, on the east by Vermont, Massachusetts, and Connecticut, on the south by the Atlantic Ocean, New Jersey, and Pennsylvania, and on the west by Pennsylvania, Lake Erie, and Canada.
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011251 Pregnancy Complications, Infectious The co-occurrence of pregnancy and an INFECTION. The infection may precede or follow FERTILIZATION. Complications, Infectious Pregnancy,Infectious Pregnancy Complications,Maternal Sepsis,Pregnancy, Infectious Complications,Sepsis during Pregnancy,Sepsis in Pregnancy,Infectious Pregnancy Complication,Pregnancy Complication, Infectious,Sepsis in Pregnancies,Sepsis, Maternal
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000086382 COVID-19 A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent. 2019 Novel Coronavirus Disease,2019 Novel Coronavirus Infection,2019-nCoV Disease,2019-nCoV Infection,COVID-19 Pandemic,COVID-19 Pandemics,COVID-19 Virus Disease,COVID-19 Virus Infection,Coronavirus Disease 2019,Coronavirus Disease-19,SARS Coronavirus 2 Infection,SARS-CoV-2 Infection,Severe Acute Respiratory Syndrome Coronavirus 2 Infection,COVID19,2019 nCoV Disease,2019 nCoV Infection,2019-nCoV Diseases,2019-nCoV Infections,COVID 19,COVID 19 Pandemic,COVID 19 Virus Disease,COVID 19 Virus Infection,COVID-19 Virus Diseases,COVID-19 Virus Infections,Coronavirus Disease 19,Disease 2019, Coronavirus,Disease, 2019-nCoV,Disease, COVID-19 Virus,Infection, 2019-nCoV,Infection, COVID-19 Virus,Infection, SARS-CoV-2,Pandemic, COVID-19,SARS CoV 2 Infection,SARS-CoV-2 Infections,Virus Disease, COVID-19,Virus Infection, COVID-19
D000086402 SARS-CoV-2 A species of BETACORONAVIRUS causing atypical respiratory disease (COVID-19) in humans. The organism was first identified in 2019 in Wuhan, China. The natural host is the Chinese intermediate horseshoe bat, RHINOLOPHUS affinis. 2019 Novel Coronavirus,COVID-19 Virus,COVID19 Virus,Coronavirus Disease 2019 Virus,SARS Coronavirus 2,SARS-CoV-2 Virus,Severe Acute Respiratory Syndrome Coronavirus 2,Wuhan Coronavirus,Wuhan Seafood Market Pneumonia Virus,2019-nCoV,2019 Novel Coronaviruses,COVID 19 Virus,COVID-19 Viruses,COVID19 Viruses,Coronavirus 2, SARS,Coronavirus, 2019 Novel,Coronavirus, Wuhan,Novel Coronavirus, 2019,SARS CoV 2 Virus,SARS-CoV-2 Viruses,Virus, COVID-19,Virus, COVID19,Virus, SARS-CoV-2,Viruses, COVID19
D000087124 COVID-19 Serological Testing Diagnosis of COVID-19 by assaying bodily fluids or tissues for the presence antibodies specific to SARS-COV-2 or its antigens. COVID-19 Antibody Testing,COVID-19 Serodiagnosis,COVID19 Antibody Testing,COVID19 Serodiagnosis,COVID19 Serological Testing,SARS-COV-2 Antigen Testing,SARS-CoV-2 Infection Antibody Testing,SARS-CoV-2 Infection Serological Testing,Serology Testing for COVID-19,Antibody Testing, COVID-19,Antibody Testing, COVID19,Antigen Testings, SARS-COV-2,COVID 19 Antibody Testing,COVID 19 Serodiagnosis,COVID 19 Serological Testing,COVID-19 Antibody Testings,COVID-19 Serodiagnoses,COVID-19 Serological Testings,COVID19 Antibody Testings,COVID19 Serodiagnoses,COVID19 Serological Testings,SARS COV 2 Antigen Testing,SARS CoV 2 Infection Antibody Testing,SARS CoV 2 Infection Serological Testing,SARS-COV-2 Antigen Testings,Serodiagnosis, COVID-19,Serodiagnosis, COVID19,Serological Testing, COVID-19,Serological Testing, COVID19,Serology Testing for COVID 19,Testing, COVID-19 Antibody,Testing, COVID-19 Serological,Testing, COVID19 Antibody,Testing, COVID19 Serological,Testing, SARS-COV-2 Antigen
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies
D015415 Biomarkers Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc. Biochemical Markers,Biological Markers,Biomarker,Clinical Markers,Immunologic Markers,Laboratory Markers,Markers, Biochemical,Markers, Biological,Markers, Clinical,Markers, Immunologic,Markers, Laboratory,Markers, Serum,Markers, Surrogate,Markers, Viral,Serum Markers,Surrogate Markers,Viral Markers,Biochemical Marker,Biologic Marker,Biologic Markers,Clinical Marker,Immune Marker,Immune Markers,Immunologic Marker,Laboratory Marker,Marker, Biochemical,Marker, Biological,Marker, Clinical,Marker, Immunologic,Marker, Laboratory,Marker, Serum,Marker, Surrogate,Serum Marker,Surrogate End Point,Surrogate End Points,Surrogate Endpoint,Surrogate Endpoints,Surrogate Marker,Viral Marker,Biological Marker,End Point, Surrogate,End Points, Surrogate,Endpoint, Surrogate,Endpoints, Surrogate,Marker, Biologic,Marker, Immune,Marker, Viral,Markers, Biologic,Markers, Immune

Related Publications

Lylach Haizler-Cohen, and Adi Davidov, and Matthew J Blitz, and Gary Fruhman
August 2020, American journal of obstetrics and gynecology,
Lylach Haizler-Cohen, and Adi Davidov, and Matthew J Blitz, and Gary Fruhman
November 2020, American journal of obstetrics and gynecology,
Lylach Haizler-Cohen, and Adi Davidov, and Matthew J Blitz, and Gary Fruhman
January 2021, Obstetrics and gynecology,
Lylach Haizler-Cohen, and Adi Davidov, and Matthew J Blitz, and Gary Fruhman
August 2020, Obstetrics and gynecology,
Lylach Haizler-Cohen, and Adi Davidov, and Matthew J Blitz, and Gary Fruhman
November 2020, American journal of obstetrics & gynecology MFM,
Lylach Haizler-Cohen, and Adi Davidov, and Matthew J Blitz, and Gary Fruhman
July 2021, American journal of obstetrics and gynecology,
Lylach Haizler-Cohen, and Adi Davidov, and Matthew J Blitz, and Gary Fruhman
May 2021, American journal of obstetrics and gynecology,
Lylach Haizler-Cohen, and Adi Davidov, and Matthew J Blitz, and Gary Fruhman
January 2021, European journal of obstetrics, gynecology, and reproductive biology,
Lylach Haizler-Cohen, and Adi Davidov, and Matthew J Blitz, and Gary Fruhman
March 2022, Clinics in laboratory medicine,
Lylach Haizler-Cohen, and Adi Davidov, and Matthew J Blitz, and Gary Fruhman
November 2020, American journal of obstetrics and gynecology,
Copied contents to your clipboard!